Well I thought I join you all on the slide to oblivion. Seriously though - there is a massive risk discount here for the problems with Didipio (maybe justifiably so). If they can bring it into production over the next year there will be a massive rerating of OGC. Worth a punt I reckon.
- Forums
- ASX - By Stock
- OGC
- i am in
i am in
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OGC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online